Jonathan W. Uzorka

ORCID: 0000-0003-2296-9667
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Infectious Diseases and Tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • SARS-CoV-2 and COVID-19 Research
  • Pneumonia and Respiratory Infections
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Parasitic Infections and Diagnostics
  • Toxoplasma gondii Research Studies
  • Antimicrobial Resistance in Staphylococcus
  • Diagnosis and treatment of tuberculosis
  • vaccines and immunoinformatics approaches

Leiden University Medical Center
2017-2024

Leiden University
2017-2019

Anna H.E. Roukens Cilia R. Pothast Marion König Wesley Huisman Tim J. Dalebout and 92 more Tamar Tak Shohreh Azimi Yvonne C. M. Kruize Renate S. Hagedoorn Mihaela Zlei Frank J. T. Staal Fenna De Bie Jacques J. M. van Dongen M. Sesmu Arbous Jaimie L. H. Zhang Maaike Verheij Corine Prins Anne M. van der Does Pieter S. Hiemstra Jutte J.C. de Vries Jacqueline J. Janse Meta Roestenberg Sebenzile K. Myeni Marjolein Kikkert Maria Yazdanbakhsh Mirjam H.M. Heemskerk Hermelijn H. Smits Simon P. Jochems M. Sesmu Arbous Bernard M. van den Berg Sandra de Bruin-Versteeg Suzanne C. Cannegieter K. Canté Christa M. Cobbaert Anne M. van der Does Jacques J. M. van Dongen Jeroen Eikenboom Mariet C.W. Feltkamp Annemieke Geluk Jelle J. Goeman Martin Giera Rick J. Groenland Thomas Hankemeier Mirjam H.M. Heemskerk Pieter S. Hiemstra Cornelis H. Hokke Rosalie van der Holst Jacqueline J. Janse Simon P. Jochems Simone A. Joosten Marjolein Kikkert S. Klaver Flores Lieke Lamont Judith Manniën Bas de Mooij Tom H. M. Ottenhoff Karin Pike‐Overzet Tamás Pongrácz Michaela Prado N. Queralt Rosinach Meta Roestenberg Marco Roos Anna H.E. Roukens Alita J. van der Sluijs‐Gelling Hermelijn H. Smits Eric J. Snijder Frank J. T. Staal Leendert A. Trouw Roula Tsonaka Aswin Verhoeven Leo G. Visser Jutte J.C. de Vries David J. van Westerloo Jeanette Wigbers H.J. van Wijk Robin C. van Wissen Manfred Wuhrer Maria Yazdanbakhsh Mihaela Zlei Josine A. Oud Meryem Baysan Jeanette Wigbers Lieke J. van Heurn Susan B. ter Haar Alexandra G. L. Toppenberg Laura Heerdink Annekee A. van IJlzinga Veenstra Anna M. Eikenboom Julia M. Wubbolts Jonathan W. Uzorka Willem M. Lijfering Romy Meier I. De Jonge Mark de Boer Anske G. van der Bom Olaf M. Dekkers Frits R. Rosendaal

10.1038/s41590-021-01095-w article EN Nature Immunology 2021-12-22

Background Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) testing. Previous studies showed that two-thirds of patients with negative QFT results just below the cut-off, so-called borderline test results, nevertheless had other evidence TB infection. This study aimed to identify a biomarker profile by which due can be distinguished from random variation. Methods supernatants (≥0.15 and <0.35 IU·mL −1 ), low-negative (<0.15 ) or positive (≥0.35...

10.1183/13993003.02665-2021 article EN cc-by-nc European Respiratory Journal 2022-01-20

QuantiFERON (QFT) results near the cut-off are subject to debate. We aimed investigate which borderline QFT were due Mycobacterium tuberculosis (Mtb)-specific responses or test variability.In a contact investigation, tuberculin skin (TST), and T-SPOT.TB (T-SPOT) performed in 785 BCG-unvaccinated contacts. Contacts with low-negative (<0.15), (0.15-0.35), low-positive (0.35-0.70) high-positive (≥0.70 IU/mL) compared respect exposure, TST T-SPOT results. Development of active was...

10.1016/j.tube.2018.06.002 article EN cc-by-nc-nd Tuberculosis 2018-06-07

Abstract SARS-CoV2 infection results in a range of disease severities, but the underlying differential pathogenesis is still not completely understood. At presentation it remains difficult to estimate and predict severity, particular, identify individuals at greatest risk progression towards most severe disease-states. Here we used advanced models with circulating serum analytes as variables combination daily assessment severity using SCODA-score, only single time points also during course...

10.1038/s41598-024-63586-8 article EN cc-by Scientific Reports 2024-06-05

Several radiological features have been reported in association with latent tuberculosis infection (LTBI) but it has not studied which are specific. The aim of this study was to evaluate allegedly characteristic abnormalities on chest radiography (CXR) patients LTBI compared uninfected controls.From 236 tested QuantiFERON-TB Gold In-Tube (QFT), the CXR re-evaluated a blinded fashion for fibrotic scarring, (non-)calcified nodules and pleural thickening. defined as presence positive QFT result...

10.1016/j.jctube.2019.01.004 article EN cc-by-nc-nd Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2019-01-27

While postnatal toxoplasmosis in immune-competent patients is generally considered a self-limiting and mild illness, it has been associated with variety of more severe clinical manifestations. The causal relation some manifestations, e.g. myocarditis, microbiologically proven, but this not unequivocally so for other reported associations, such as epilepsy. We aimed to systematically assess causality between epilepsy patients. A literature search was performed. Bradford Hill criteria were...

10.1007/s10096-016-2897-0 article EN cc-by European Journal of Clinical Microbiology & Infectious Diseases 2017-01-12

Abstract Screening for latent tuberculosis infection (LTBI) is indicated before immunosuppressive therapies but complicated by lack of a gold standard and limited by, e.g., immunosuppression. This study aimed to investigate series patients diagnosed with LTBI during screening therapy, describing how the use diagnostic tests treatment evolved over time. retrospective cohort included all individuals intended therapy in tertiary care hospital between January 2000 December 2017. Evidence LTBI,...

10.1007/s10096-020-03850-7 article EN cc-by European Journal of Clinical Microbiology & Infectious Diseases 2020-02-20
Coming Soon ...